Latest Cardinal Health (CAH) Headlines
Quarterly Dividends, Store Sales Report, New Health Program, Company Recognition, Stock Trade Movement - Analyst Notes on CVS Caremark, Walgreens, Rite Aid, GNC, and Cardinal Health
PR Newswire - Fri Mar 14, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding CVS Caremark Corporation (NYSE: CVS), Walgreen Company (NYSE: WAG), Rite Aid Corporation (NYSE: RAD), GNC Holdings Inc (NYSE: GNC), and Cardinal Health Inc (NYSE: CAH). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Medication Safety Toolkit Available for National Poison Prevention Week
PR Newswire - Thu Mar 13, 11:00AM CDT
According to a recent study conducted by Safe Kids Worldwide, more than 67,000 children were treated in emergency departments for medicine poisoning in 2011. The increased accessibility of prescription and over-the-counter medicines, coupled with children's natural curiosity, makes it important to educate today's youth in medication safety at an early age.
CR Bard Reaches New 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 12, 8:10AM CDT
Shares of BCR started escalating following optimism triggered by promising 2014 guidance.
Cardinal Health Shares Up 62.6% Since SmarTrend's Buy Recommendation (CAH)
Comtex SmarTrend(R) - Mon Mar 10, 11:02AM CDT
SmarTrend identified an Uptrend for Cardinal Health (NYSE:CAH) on April 24th, 2013 at $44.18. In approximately 11 months, Cardinal Health has returned 62.65% as of today's recent price of $71.85.
APNewsBreak: Delaware lacks lethal injection drugs
By RANDALL CHASE - AP - Thu Mar 06, 5:56AM CST
DOVER, Del. (AP) — Delaware has 17 condemned prisoners facing the death penalty, but no means of executing any of them.
Successful Acquisitions, Stock Price Updates, Accolades, and Dividend Declarations - Analyst Notes on Cardinal Health, AmerisourceBergen, Henry Schein, Patterson, and Medical Properties Trust
PR Newswire - Wed Mar 05, 3:00PM CST
Today, Analysts Review released its analysts' notes regarding Cardinal Health, Inc. (NYSE: CAH), AmerisourceBergen Corporation (NYSE: ABC), Henry Schein, Inc. (NASDAQ: HSIC), Patterson Companies Inc. (NASDAQ: PDCO), and Medical Properties Trust Inc. (NYSE: MPW). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Cardinal Health Has Returned 61.7% Since SmarTrend Recommendation (CAH)
Comtex SmarTrend(R) - Mon Mar 03, 9:39AM CST
SmarTrend identified an Uptrend for Cardinal Health (NYSE:CAH) on April 24th, 2013 at $44.18. In approximately 10 months, Cardinal Health has returned 61.72% as of today's recent price of $71.44.
Henry Schein, P&G Sign Distribution Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 28, 3:00PM CST
Recently, Henry Schein inked a distribution deal with The Procter & Gamble Company.
Global Medical Electrodes Market Forecasts & Opportunities, 2018
M2 - Thu Feb 27, 4:59AM CST
Research and Markets (http://www.researchandmarkets.com/research/5hvqsv/global_medical) has announced the addition of the "Global Medical Electrodes Market Forecasts & Opportunities, 2018" report to their offering. Reusable electrodes present risks of cross contamination leading to hospital acquired infections. Commonly referred to as nosocomial infections, these infections affect about 1.7 million of the US population every year causing the death of roughly 99,000 people. Hence, medical device equipment employing electrodes needs to be replaced to avoid hospital acquired infections. Thus, the market is currently witnessing a shift toward increase in the use of disposable electrodes. These electrodes could be used for about a week or more before discarding them. They are cost effective and flexible for use in patients. This trend is in turn expected to drive the growth of the Global Medical Device Electrodes market. According to the report, one of the major drivers in this market is the increase in the aging population. The rising aging population is contributing toward an increase in usage of medical devices. This in turn is driving the growth of the Global Medical Device Electrodes market. Further, the report states that one of the main challenges in this market is pricing pressures. Fluctuations in the price of metals and by-products of petrol such as plastic could affect the price rate of the supplies within the supply chain. Key Topics Covered: 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 04. Market Research Methodology 05. Introduction 06. Market Landscape 07. Geographical Segmentation 08. Buying Criteria 09. Market Growth Drivers 10. Drivers and their Impact 11. Market Challenges 12. Impact of Drivers and Challenges 13. Market Trends 14. Trends and their Impact 15. Vendor Landscape 16. Key Vendor Analysis - 3M Corp. - Ambu A/S - CR Bard Inc. - Covidien plc. - ConMED Corp. - Cardinal Health Inc. For more information visit http://www.researchandmarkets.com/research/5h...al_medical
North American Radiopharmaceuticals Market is Poised to Reach $2.7 Billion By 2017 at a CAGR of 7.2%
M2 - Wed Feb 26, 10:00AM CST
Research and Markets (http://www.researchandmarkets.com/research/5r3ppz/north_american) has announced the addition of the "North American Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market [SPECT/PET Radioisotopes (Technetium, F-18)], [Beta/Alpha Radiation Therapy (I131, Y-90)], [Applications (Cancer/Oncology, Cardiac)] & (Deuterium, C-13) - Forecast to 2017" report to their offering. A study conducted by Organization for Economic Co-operation and Development (OECD) estimates that Tc-99m diagnostic procedures are expected to increase by 15% to 20% in mature markets such as North America between 2010 and 2030. Radiopharmaceuticals in neurological applications such as Alzheimer's disease, Parkinson's disease, and dementia are also being preferred by practitioners besides conventional treatment. Further, upcoming radioisotopes such as Ra-223 (Alpharadin) and Ga-68 possess huge potential for clinical applications. The scheduled shutdown of the NRU reactor in 2016 in Canada is, however, a major threat for manufacturers. The U.S. is the dominant market for diagnostic radioisotopes with more than 80% share. The U.S. is the largest consumer market for radiopharmaceuticals in North America, while Canada is one of the largest producers of Tc-99m. Major players in the radiopharmaceuticals market are Cardinal Health, Inc. (U.S.), Lantheus Medical Imaging, Inc. (U.S.), Nordion, Inc. (Canada), and Triad Isotopes, Inc. (U.S.). The stable isotopes market was led by two players - Cambridge Isotope Laboratories (CIL) and Sigma Aldrich - in 2012; they jointly contributed more than 90% to the North American revenue. Companies Mentioned: - Australian Nuclear Association And Technology Organization (Ansto) - Board Of Radiation And Isotope Technology (Brit) - Bracco Imaging S.P.A. - Cambridge Isotope Laboratories, Inc. - Cardinal Health, Inc. - Covidien, Plc - Eczacibasi-Monrol - Fujifilm Holdings Corporation - Ge Healthcare (Subsidiary Of General Electric Company) - Iba Group - Institute Of Atomic Energy Polatom Radioisotope Centre - Institute Of Isotopes Co., Ltd. - Institute Of Radioelement (Ire) - Isotec, Inc. (Sigma-Aldrich) - Lantheus Medical Imaging, Inc. - Nordion, Inc. - Ntp Radioisotopes (Pty), Ltd. - Petnet Solutions, Inc. (A Subsidiary Of Siemens Medical Solutions Usa, Inc.) - Rotem Industries, Ltd., Inc. - Taiyo Nippon Sanso Corporation - Triad Isotopes, Inc. - Urenco Limited For more information visit http://www.researchandmarkets.com/research/5r...h_american About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Reps Committee Commends CBN On Remmittance
All Africa Global Media - Wed Feb 26, 4:04AM CST
The House of Representatives Committee on Finance on Tuesday commended the Central Bank of Nigeria for its timely remittance to the Federation Account.
Progress Watch Corp. to Enter Social/Content Marketing Arena
Marketwire - Tue Feb 25, 9:13AM CST
Progress Watch Corporation (PINKSHEETS: PROW) announced that it will enter the social/ content marketing arena. With more than one billion smart phone users and 1.7 billion expected by 2017, this move from its traditional core business line mechanical movement manufacturing and watch supply businesses) is expected to develop new revenue streams for the company, especially in the area of social/content marketing. Companies will have the ability to target specific markets to stream branded messages.
KEW Group concludes private financing with Cardinal Health and The Bolyston Street Group
M2 - Tue Feb 25, 6:21AM CST
Oncology company KEW Group revealed on Monday the completion of a private round of financing with Cardinal Health (NYSE:CAH) and The Bolyston Street Group.
EnteroMedics to Present at the Cowen and Company 34th Annual Health Care Conference
Marketwire - Tue Feb 25, 6:01AM CST
EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that Mark B. Knudson, Ph.D., EnteroMedics' President and Chief Executive Officer, is scheduled to present at the Cowen and Company 34th Annual Health Care Conference on March 5, 2014 at 10:00 am Eastern Time at the Boston Marriott Copley Place in Boston, MA.
KEW Group Inc. Announces Completion of Private Financing Round
PR Newswire - Mon Feb 24, 10:05AM CST
KEW Group Inc. (KEW), a privately held oncology services company located in Cambridge, Mass., announced today the recent closing of a private round of financing with Cardinal Health (NYSE: CAH) and The Bolyston Street Group. KEW is focused on providing state-of-the-art diagnostic services to help inform and advance community oncologists' treatment decisions for their patients.
Concise Analysis of the International Laparoscopic Devices Market
M2 - Mon Feb 24, 5:29AM CST
Research and Markets (http://www.researchandmarkets.com/research/pf5jcf/laparoscopic) has announced the addition of the "Concise Analysis of the International Laparoscopic Devices Market" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is also provided for these markets. Market data and analytics are derived from primary and secondary research. This report analyzes the worldwide markets for Laparoscopic Devices in US$ Thousand by the following Product Segments: - Laparoscopes - Trocars - Insufflation and Suction/Irrigation Devices - Closure Devices - Hand Instruments - Direct Energy Devices - Gastric Band - Hand Assist Devices - Other Devices. Company profiles are primarily based on public domain information including company URLs. The report profiles 82 companies including many key and niche players such as: - Allergan, Inc. - B. Braun Melsungen AG - Aesculap AG - Boston Scientific Corp. - Cardinal Health, Inc. - Conmed Corporation Covidien Ltd. Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. For information on site licence pricing please click on Enquire before buying. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Global Market Overview 2. Market Dynamics 3. Market Trends 4. Issues And Challenges 5. Product Overview 6. Laparoscopy - An Overview 7. Laparoscopic Surgical Procedures 8. Market Segmentation 9. Product Innovations/Introductions 10. Recent Industry Activity 11. Focus On Select Global Players 12. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Middle East 7. Latin America IV. Competitive Landscape Total Companies Profiled: 82 (including Divisions/Subsidiaries - 92) - The United States (46) - Canada (1) Japan (1) - Europe (39) - France (3) - Germany (27) - The United Kingdom (3) - Rest of Europe (6) - Asia-Pacific (Excluding Japan) (1) - Middle-East (1) For more information visit http://www.researchandmarkets.com/research/pf...paroscopic
EURO RESSOURCES REPORTS EARNINGS FOR THE YEAR ENDED DECEMBER 31, 2013
GlobeNewswire - Fri Feb 21, 5:48PM CST
EURO Ressources S.A. ("EURO" or the "Company") (Paris: EUR) today announced its audited statutory financial results prepared in accordance with French Generally Accepted Accounting Principles ("GAAP") and its audited financial results prepared in accordance with International Financial Reporting Standards ("IFRS") for the year ended December 31, 2013. These audited financial results were approved by the Board of Directors on February 21, 2014. All financial amounts are expressed in Euros unless otherwise specified.
Express Scripts Reports In-Line Earnings in Q4 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 21, 11:00AM CST
Express Scripts posted fourth quarter 2013 earnings per share (excluding special items) of $1.12, up from $1.05 reported in the year-ago quarter and in line with the Zacks Consensus Estimate
McKesson Expands Agreement with Rite Aid - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 19, 5:10PM CST
McKesson Corporation recently announced that it has expanded its distribution agreement with Rite Aid Corporation (RAD).
Quarterly Dividends, Store Sales Report, New Health Program, Company Recognition, Stock Trade Movement - Analyst Notes on CVS Caremark, Walgreens, Rite Aid, GNC, and Cardinal Health
PR Newswire - Fri Mar 14, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding CVS Caremark Corporation (NYSE: CVS), Walgreen Company (NYSE: WAG), Rite Aid Corporation (NYSE: RAD), GNC Holdings Inc (NYSE: GNC), and Cardinal Health Inc (NYSE: CAH). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Medication Safety Toolkit Available for National Poison Prevention Week
PR Newswire - Thu Mar 13, 11:00AM CDT
According to a recent study conducted by Safe Kids Worldwide, more than 67,000 children were treated in emergency departments for medicine poisoning in 2011. The increased accessibility of prescription and over-the-counter medicines, coupled with children's natural curiosity, makes it important to educate today's youth in medication safety at an early age.
CR Bard Reaches New 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 12, 8:10AM CDT
Shares of BCR started escalating following optimism triggered by promising 2014 guidance.
Cardinal Health Shares Up 62.6% Since SmarTrend's Buy Recommendation (CAH)
Comtex SmarTrend(R) - Mon Mar 10, 11:02AM CDT
SmarTrend identified an Uptrend for Cardinal Health (NYSE:CAH) on April 24th, 2013 at $44.18. In approximately 11 months, Cardinal Health has returned 62.65% as of today's recent price of $71.85.
APNewsBreak: Delaware lacks lethal injection drugs
By RANDALL CHASE - AP - Thu Mar 06, 5:56AM CST
DOVER, Del. (AP) — Delaware has 17 condemned prisoners facing the death penalty, but no means of executing any of them.
Successful Acquisitions, Stock Price Updates, Accolades, and Dividend Declarations - Analyst Notes on Cardinal Health, AmerisourceBergen, Henry Schein, Patterson, and Medical Properties Trust
PR Newswire - Wed Mar 05, 3:00PM CST
Today, Analysts Review released its analysts' notes regarding Cardinal Health, Inc. (NYSE: CAH), AmerisourceBergen Corporation (NYSE: ABC), Henry Schein, Inc. (NASDAQ: HSIC), Patterson Companies Inc. (NASDAQ: PDCO), and Medical Properties Trust Inc. (NYSE: MPW). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Cardinal Health Has Returned 61.7% Since SmarTrend Recommendation (CAH)
Comtex SmarTrend(R) - Mon Mar 03, 9:39AM CST
SmarTrend identified an Uptrend for Cardinal Health (NYSE:CAH) on April 24th, 2013 at $44.18. In approximately 10 months, Cardinal Health has returned 61.72% as of today's recent price of $71.44.
Henry Schein, P&G Sign Distribution Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 28, 3:00PM CST
Recently, Henry Schein inked a distribution deal with The Procter & Gamble Company.
Global Medical Electrodes Market Forecasts & Opportunities, 2018
M2 - Thu Feb 27, 4:59AM CST
Research and Markets (http://www.researchandmarkets.com/research/5hvqsv/global_medical) has announced the addition of the "Global Medical Electrodes Market Forecasts & Opportunities, 2018" report to their offering. Reusable electrodes present risks of cross contamination leading to hospital acquired infections. Commonly referred to as nosocomial infections, these infections affect about 1.7 million of the US population every year causing the death of roughly 99,000 people. Hence, medical device equipment employing electrodes needs to be replaced to avoid hospital acquired infections. Thus, the market is currently witnessing a shift toward increase in the use of disposable electrodes. These electrodes could be used for about a week or more before discarding them. They are cost effective and flexible for use in patients. This trend is in turn expected to drive the growth of the Global Medical Device Electrodes market. According to the report, one of the major drivers in this market is the increase in the aging population. The rising aging population is contributing toward an increase in usage of medical devices. This in turn is driving the growth of the Global Medical Device Electrodes market. Further, the report states that one of the main challenges in this market is pricing pressures. Fluctuations in the price of metals and by-products of petrol such as plastic could affect the price rate of the supplies within the supply chain. Key Topics Covered: 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 04. Market Research Methodology 05. Introduction 06. Market Landscape 07. Geographical Segmentation 08. Buying Criteria 09. Market Growth Drivers 10. Drivers and their Impact 11. Market Challenges 12. Impact of Drivers and Challenges 13. Market Trends 14. Trends and their Impact 15. Vendor Landscape 16. Key Vendor Analysis - 3M Corp. - Ambu A/S - CR Bard Inc. - Covidien plc. - ConMED Corp. - Cardinal Health Inc. For more information visit http://www.researchandmarkets.com/research/5h...al_medical
North American Radiopharmaceuticals Market is Poised to Reach $2.7 Billion By 2017 at a CAGR of 7.2%
M2 - Wed Feb 26, 10:00AM CST
Research and Markets (http://www.researchandmarkets.com/research/5r3ppz/north_american) has announced the addition of the "North American Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market [SPECT/PET Radioisotopes (Technetium, F-18)], [Beta/Alpha Radiation Therapy (I131, Y-90)], [Applications (Cancer/Oncology, Cardiac)] & (Deuterium, C-13) - Forecast to 2017" report to their offering. A study conducted by Organization for Economic Co-operation and Development (OECD) estimates that Tc-99m diagnostic procedures are expected to increase by 15% to 20% in mature markets such as North America between 2010 and 2030. Radiopharmaceuticals in neurological applications such as Alzheimer's disease, Parkinson's disease, and dementia are also being preferred by practitioners besides conventional treatment. Further, upcoming radioisotopes such as Ra-223 (Alpharadin) and Ga-68 possess huge potential for clinical applications. The scheduled shutdown of the NRU reactor in 2016 in Canada is, however, a major threat for manufacturers. The U.S. is the dominant market for diagnostic radioisotopes with more than 80% share. The U.S. is the largest consumer market for radiopharmaceuticals in North America, while Canada is one of the largest producers of Tc-99m. Major players in the radiopharmaceuticals market are Cardinal Health, Inc. (U.S.), Lantheus Medical Imaging, Inc. (U.S.), Nordion, Inc. (Canada), and Triad Isotopes, Inc. (U.S.). The stable isotopes market was led by two players - Cambridge Isotope Laboratories (CIL) and Sigma Aldrich - in 2012; they jointly contributed more than 90% to the North American revenue. Companies Mentioned: - Australian Nuclear Association And Technology Organization (Ansto) - Board Of Radiation And Isotope Technology (Brit) - Bracco Imaging S.P.A. - Cambridge Isotope Laboratories, Inc. - Cardinal Health, Inc. - Covidien, Plc - Eczacibasi-Monrol - Fujifilm Holdings Corporation - Ge Healthcare (Subsidiary Of General Electric Company) - Iba Group - Institute Of Atomic Energy Polatom Radioisotope Centre - Institute Of Isotopes Co., Ltd. - Institute Of Radioelement (Ire) - Isotec, Inc. (Sigma-Aldrich) - Lantheus Medical Imaging, Inc. - Nordion, Inc. - Ntp Radioisotopes (Pty), Ltd. - Petnet Solutions, Inc. (A Subsidiary Of Siemens Medical Solutions Usa, Inc.) - Rotem Industries, Ltd., Inc. - Taiyo Nippon Sanso Corporation - Triad Isotopes, Inc. - Urenco Limited For more information visit http://www.researchandmarkets.com/research/5r...h_american About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Reps Committee Commends CBN On Remmittance
All Africa Global Media - Wed Feb 26, 4:04AM CST
The House of Representatives Committee on Finance on Tuesday commended the Central Bank of Nigeria for its timely remittance to the Federation Account.
Progress Watch Corp. to Enter Social/Content Marketing Arena
Marketwire - Tue Feb 25, 9:13AM CST
Progress Watch Corporation (PINKSHEETS: PROW) announced that it will enter the social/ content marketing arena. With more than one billion smart phone users and 1.7 billion expected by 2017, this move from its traditional core business line mechanical movement manufacturing and watch supply businesses) is expected to develop new revenue streams for the company, especially in the area of social/content marketing. Companies will have the ability to target specific markets to stream branded messages.
KEW Group concludes private financing with Cardinal Health and The Bolyston Street Group
M2 - Tue Feb 25, 6:21AM CST
Oncology company KEW Group revealed on Monday the completion of a private round of financing with Cardinal Health (NYSE:CAH) and The Bolyston Street Group.
EnteroMedics to Present at the Cowen and Company 34th Annual Health Care Conference
Marketwire - Tue Feb 25, 6:01AM CST
EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that Mark B. Knudson, Ph.D., EnteroMedics' President and Chief Executive Officer, is scheduled to present at the Cowen and Company 34th Annual Health Care Conference on March 5, 2014 at 10:00 am Eastern Time at the Boston Marriott Copley Place in Boston, MA.
KEW Group Inc. Announces Completion of Private Financing Round
PR Newswire - Mon Feb 24, 10:05AM CST
KEW Group Inc. (KEW), a privately held oncology services company located in Cambridge, Mass., announced today the recent closing of a private round of financing with Cardinal Health (NYSE: CAH) and The Bolyston Street Group. KEW is focused on providing state-of-the-art diagnostic services to help inform and advance community oncologists' treatment decisions for their patients.
Concise Analysis of the International Laparoscopic Devices Market
M2 - Mon Feb 24, 5:29AM CST
Research and Markets (http://www.researchandmarkets.com/research/pf5jcf/laparoscopic) has announced the addition of the "Concise Analysis of the International Laparoscopic Devices Market" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is also provided for these markets. Market data and analytics are derived from primary and secondary research. This report analyzes the worldwide markets for Laparoscopic Devices in US$ Thousand by the following Product Segments: - Laparoscopes - Trocars - Insufflation and Suction/Irrigation Devices - Closure Devices - Hand Instruments - Direct Energy Devices - Gastric Band - Hand Assist Devices - Other Devices. Company profiles are primarily based on public domain information including company URLs. The report profiles 82 companies including many key and niche players such as: - Allergan, Inc. - B. Braun Melsungen AG - Aesculap AG - Boston Scientific Corp. - Cardinal Health, Inc. - Conmed Corporation Covidien Ltd. Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. For information on site licence pricing please click on Enquire before buying. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Global Market Overview 2. Market Dynamics 3. Market Trends 4. Issues And Challenges 5. Product Overview 6. Laparoscopy - An Overview 7. Laparoscopic Surgical Procedures 8. Market Segmentation 9. Product Innovations/Introductions 10. Recent Industry Activity 11. Focus On Select Global Players 12. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Middle East 7. Latin America IV. Competitive Landscape Total Companies Profiled: 82 (including Divisions/Subsidiaries - 92) - The United States (46) - Canada (1) Japan (1) - Europe (39) - France (3) - Germany (27) - The United Kingdom (3) - Rest of Europe (6) - Asia-Pacific (Excluding Japan) (1) - Middle-East (1) For more information visit http://www.researchandmarkets.com/research/pf...paroscopic
EURO RESSOURCES REPORTS EARNINGS FOR THE YEAR ENDED DECEMBER 31, 2013
GlobeNewswire - Fri Feb 21, 5:48PM CST
EURO Ressources S.A. ("EURO" or the "Company") (Paris: EUR) today announced its audited statutory financial results prepared in accordance with French Generally Accepted Accounting Principles ("GAAP") and its audited financial results prepared in accordance with International Financial Reporting Standards ("IFRS") for the year ended December 31, 2013. These audited financial results were approved by the Board of Directors on February 21, 2014. All financial amounts are expressed in Euros unless otherwise specified.
Express Scripts Reports In-Line Earnings in Q4 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 21, 11:00AM CST
Express Scripts posted fourth quarter 2013 earnings per share (excluding special items) of $1.12, up from $1.05 reported in the year-ago quarter and in line with the Zacks Consensus Estimate
McKesson Expands Agreement with Rite Aid - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 19, 5:10PM CST
McKesson Corporation recently announced that it has expanded its distribution agreement with Rite Aid Corporation (RAD).
